Editorial · About this project
About Dr PT-141: an independent PT-141 research digest.
What this site is, what it is not, and why the "dr" in the name is a position relative to the literature — not a claim about services.
What Dr PT-141 is
Dr PT-141 is an independent editorial project that publishes summaries of the peer-reviewed research literature on PT-141 (bremelanotide). We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science — the published trials, the FDA prescribing information, and the preclinical record — compiled and cited so a reader can find the source for every figure we report.
What the "dr" means here
The "dr" in the domain name is editorial framing, not a clinical credential. It signals the register this site occupies relative to the literature: a plain, unembellished clinical-record reading — the label finding and the trial number printed without bedside polish or a storefront gloss. It is not a claim that this site is a doctor, a clinic, or a prescriber, and it is not an offer of consultation, treatment, or prescription. No physician stands behind this page; what stands behind it is the cited record. Any decision about a drug belongs to a qualified clinician who knows the individual.
How we handle the evidence
We separate what the trials confirmed from what they did not, and we keep community anecdote out of the cited record entirely. Confirmed findings — the RECONNECT coprimary endpoints, the 52-week extension, the fMRI mechanism — are reported with their numbers and sources [3][4][5]. Honest gaps — the modest effect size and the independent re-analyses, the absence of any approval beyond premenopausal HSDD, the lack of oversight on "research chemical" material — are marked as gaps, not smoothed over. And unverified first-hand reports are quarantined in a clearly-labelled "field reports" section, never attributed to a journal. The goal is a document a reader can trust precisely because it does not flatter the compound.
What this site does not do
This site does not sell, source, price, or supply PT-141 or any other compound, and it does not tell anyone to take it. It does not offer medical advice, diagnosis, or treatment, and it does not host a store or a vendor directory. It summarizes published research and the approved label, and it points to the original sources. If you are weighing anything described here, the right next step is a conversation with a qualified clinician — not this page.